Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity

摘要

In the published article, there was an error in affiliations 1 and 2. Instead of “Roche Pharmaceutical Research & Early Development”, it should be “Roche Pharma Research & Early Development”.